Promoter Docon Technologies Private Limited had 1.75 crore shares of Thyrocare Technologies released from pledge on August 11, 2026. This mechanical adjustment reduced its total encumbered shares without changing its overall stake.
A healthcare diagnostics provider, Thyrocare Technologies operates a network of diagnostic centers across India delivering laboratory testing and pathology services. The company partners with hospitals, clinics, and independent laboratories to offer affordable diagnostic solutions to patients nationwide. Its distinctive approach combines technology-enabled operations with cost-effective service delivery, making quality diagnostic care accessible across urban and semi-urban markets in India.